Viewing Study NCT04782193

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2025-12-27 @ 11:02 PM
Study NCT ID: NCT04782193
Status: UNKNOWN
Last Update Posted: 2023-04-18
First Post: 2021-02-26
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
Sponsor: Chongqing Precision Biotech Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CD19 View
None CD22 View
None CAR-T View